Nano-X CEO buys 9,443 shares in August 2026

Nano-X Imaging Ltd. director and Chief Executive Officer Erez Meltzer reported purchasing 9,443 Ordinary Shares on August 10, 2026 at $1.03 per share.

Rhea-AI Filing Summary

Nano-X Imaging Ltd. director and Chief Executive Officer Erez Meltzer reported purchasing 9,443 Ordinary Shares on August 10, 2026 at $1.03 per share. The shares were bought indirectly through Oud Nof, a company wholly owned by him, bringing that entity’s holdings to 45,443 Ordinary Shares. He also reports direct ownership of 60,584 Ordinary Shares, and three existing stock option grants over 40,234, 300,000, and 150,000 underlying Ordinary Shares at exercise prices of $2.21, $23.84, and $11.52, expiring in 2030, 2032, and 2034, respectively. The later option grant from April 16, 2024 vests over four years and is scheduled to be fully vested by April 16, 2028.

Insider Trade Summary

Net Buyer: 9,443 shares

Net Buy 5 txns

Insider Meltzer Erez

Role Chief Executive Officer

Bought 9,443 shs ($10K)

Type	Security	Shares	Price	Value
Purchase	Ordinary Shares F1	9,443	$1.03	$10K
holding	Stock Option (right to buy ordinary shares) F2, F3	--	--	--
holding	Stock Option (right to buy ordinary shares) F2, F4	--	--	--
holding	Stock Option (right to buy ordinary shares) F2, F5	--	--	--
holding	Ordinary Shares F2	--	--	--

Holdings After Transaction: Ordinary Shares — 45,443 shares (Indirect, By a wholly owned company); Stock Option (right to buy ordinary shares) — 490,234 contracts (Direct); Ordinary Shares — 60,584 shares (Direct)

Footnotes (5)

1. F1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
2. F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
3. F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
4. F4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
5. F5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Key Figures

Shares purchased: 9,443 Ordinary Shares Purchase price: $1.03 per share Indirect holdings after transaction: 45,443 Ordinary Shares +3 more

6 metrics

Shares purchased 9,443 Ordinary Shares Indirect purchase on August 10, 2026

Purchase price $1.03 per share Price for 9,443 Ordinary Shares purchased

Indirect holdings after transaction 45,443 Ordinary Shares Held through wholly owned company Oud Nof

Direct Ordinary Share holdings 60,584 Ordinary Shares Reported direct ownership position

Option exercise price $2.21 Stock option over 40,234 underlying shares expiring 2030-02-11

Largest option grant size 300,000 underlying shares Stock option at $23.84 exercise price expiring 2032-01-02

Key Terms

indirect ownership, fully vested and exercisable, vesting schedule, Rule 10b5-1

4 terms

indirect ownership financial

"Indirect ownership is noted as "By a wholly owned company" for the purchase."

fully vested and exercisable financial

"The options reported in this row were granted ... and are fully vested and exercisable."

vesting schedule financial

"The options ... vest and become exercisable in accordance with the following schedule."

A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

Rule 10b5-1 regulatory

"The filing’s Rule 10b5-1 checkbox is not checked for this transaction."

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nano-X Imaging (NNOX) report for Erez Meltzer?

Erez Meltzer reported purchasing 9,443 Ordinary Shares of Nano-X Imaging on August 10, 2026 at $1.03 per share, an indirect open-market or private transaction through a wholly owned company.

How many Nano-X Imaging (NNOX) shares does Erez Meltzer now hold indirectly?

After the August 10, 2026 transaction, a wholly owned company of Erez Meltzer holds 45,443 Ordinary Shares of Nano-X Imaging, as reported in the Form 4 filing’s non-derivative ownership table.

What are Erez Meltzer’s direct Ordinary Share holdings in NNOX?

The Form 4 reports that Erez Meltzer directly owns 60,584 Ordinary Shares of Nano-X Imaging. These direct holdings are listed separately from the indirectly held shares owned through his wholly owned company.

What stock options for Nano-X Imaging (NNOX) does Erez Meltzer hold?

Meltzer holds options over 40,234, 300,000, and 150,000 underlying Ordinary Shares at exercise prices of $2.21, $23.84, and $11.52, expiring in 2030, 2032, and 2034, respectively, as reported for informational purposes.

Are Erez Meltzer’s NNOX stock options vested and exercisable?

Options granted in January and February 2020 are reported as fully vested and exercisable. Options granted on April 16, 2024 vest over four years and are scheduled to be fully vested by April 16, 2028.

Was the NNOX insider share purchase under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not checked, indicating the reported August 10, 2026 purchase by Erez Meltzer’s wholly owned company was not made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 09:25 AM Accepted by SEC EDGAR 08/11/2026 - 09:24 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meltzer Erez

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol
[N/A]

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	08/10/2026		P		9,443	A	$1.03	45,443	I	By a wholly owned company(1)
Ordinary Shares(2)								60,584	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)(2)	$2.21							(3)	02/11/2030	Ordinary Shares	40,234		40,234	D
Stock Option (right to buy ordinary shares)(2)	$23.84							(4)	01/02/2032	Ordinary Shares	300,000		300,000	D
Stock Option (right to buy ordinary shares)(2)	$11.52							(5)	04/16/2034	Ordinary Shares	150,000		150,000	D

Explanation of Responses:

1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.

2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.

4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.

5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Remarks:

See Exhibit 24.1: Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)